Global Medical REIT (NYSE:GMRE) Issues Quarterly Earnings Results, Beats Expectations By $0.21 EPS

Global Medical REIT (NYSE:GMREGet Free Report) issued its quarterly earnings results on Thursday. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.01 by $0.21, Zacks reports. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%.

Global Medical REIT Stock Performance

Shares of Global Medical REIT stock traded down $0.01 during trading on Thursday, hitting $8.49. 372,634 shares of the stock were exchanged, compared to its average volume of 476,795. The stock has a market capitalization of $566.82 million, a price-to-earnings ratio of -424.04, a price-to-earnings-growth ratio of 1.43 and a beta of 1.24. The company has a fifty day moving average price of $7.94 and a 200-day moving average price of $8.75. Global Medical REIT has a 1-year low of $7.33 and a 1-year high of $10.46. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 1.26.

Global Medical REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Friday, December 20th were paid a dividend of $0.21 per share. The ex-dividend date of this dividend was Friday, December 20th. This represents a $0.84 annualized dividend and a dividend yield of 9.90%. Global Medical REIT’s dividend payout ratio is presently -4,200.00%.

About Global Medical REIT

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Stories

Earnings History for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.